Companies / BeOne Medicines Ltd.
BeOne Medicines Ltd.
Nasdaq: ONCCIK 1651308BASEL
Financials · FY2025
Ownership
1.48B shares outstanding · as of Jul 31, 2026
Ownership
| Institutions | 2.32% | 34,310,101 |
| Public float | 97.68% | 1,443,814,304 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 13
View all →| Insider | % of shares | Shares |
|---|---|---|
667, L.P.Director | — | — |
Baker Bros. Advisors (GP) LLCDirector | — | — |
Baker Bros. Advisors LPDirector | — | — |
Baker Brothers Life Sciences LPDirector | — | — |
Baker FelixDirector | — | — |
Baker JulianDirector | — | — |
Hooper Anthony CDirector | — | — |
Lee Chan HenrySVP, General Counsel | — | — |
Oyler JohnCEOChief Executive Officer · Director | — | — |
Rosenberg AaronChief Financial Officer | — | — |
Institutional holders 294
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.61B | 0.60% | |
| $1.55B | 0.35% | |
| $1.51B | 0.34% | |
| $1.21B | 0.27% | |
| $314.23M | 0.07% | |
| $241.01M | 0.06% | |
| $197.95M | 0.05% | |
| $162.09M | 0.04% | |
| $151.91M | 0.03% | |
| $132.97M | 0.03% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | ADR | $51.49M | +173K +551.32% | 204,846 0.01% of shares | high |
| Q1 2026 as of | First Trust Advisors LP 13F manager | Add | ADR | $34.33M | +116K +91.87% | 241,426 0.02% of shares | medium |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | ADR | $19.44M | +65K | 65,456 <0.01% of shares | medium |
| Q1 2026 as of | Temasek Holdings (Private) Limited 13F manager | Trim | ADR | $-16.91M | -57K -6.19% | 862,643 0.06% of shares | medium |
| Q1 2026 as of | Arrowstreet Capital, Limited Partnership 13F manager | Add | ADR | $16.11M | +54K +96.33% | 110,586 <0.01% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | ADR | $10.20M | +34K +9.72% | 378,832 0.03% of shares | medium |
| Q1 2025 as of | Barclays PLC 13F manager | Add | ADR | $9.99M | +37K +609.01% | 42,746 <0.01% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Trim | ADR | $-9.34M | -33K -54.03% | 27,886 <0.01% of shares | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ONC | ADR | 07725L102 |